The drop comes after BNB hit a record high near $860, driven by aggressive moves into the token by public companies.

Windtree said it aims to become the first NASDAQ-listed company to offer direct exposure to BNB. The treasury strategy ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

Crypto exchange Kraken will custody and manage BNB assets for Windtree Therapeutics' crypto treasury plan tied to Binance ...

BNB's price rose over 6.6% in 24 hours, driven by corporate treasury purchases and a new trade deal between the US and EU.

Windtree Therapeutics (WINT), a Nasdaq listed biotechnology company, plans to raise up to $200 million to build a treasury of ...

Liminatus Pharma and CEA Industries announce $1B combined BNB treasury allocations, driving exchange token market to $161B cap.

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

"We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy," stated Jed Latkin, CEO of Windtree. "Pending stockholder approval, the ...

BNB coin price has surged following a treasury strategy announcement from Windtree Therapeutics, a Nasdaq-listed ...